Literature DB >> 9723696

Two different IL-13 receptor chains are expressed in normal human skin fibroblasts, and IL-4 and IL-13 mediate signal transduction through a common pathway.

T Murata1, S R Husain, H Mohri, R K Puri.   

Abstract

IL-13 and IL-4, pleiotropic immune regulatory cytokines, have been shown to mediate similar prominent effects in human fibroblast cell lines. However, molecular mechanisms for their redundant effects are not known. Here, we have investigated the structure of IL-13 receptors (IL-13R) and molecular mechanisms of signal transduction through IL-13 and IL-4 receptors in non-transformed normal skin fibroblast cell lines. We demonstrate that high-affinity IL-13R is expressed in normal skin fibroblast cell lines. Upon [125I]1L-13 cross-linking, a approximately 60-70 kDa band was observed in sk559 and sk574 fibroblast cell lines. By RT-PCR analysis, mRNA for IL-13R alpha, IL-13R alpha' and IL-4Rbeta chains were expressed; however, the IL-2Rgamma chain, shown to participate and modulate IL-4 and IL-13 binding, was not expressed in any of the cell lines examined. The Janus kinase (JAK)2 and Tyk2 were phosphorylated in response to IL-4 or IL-13 in sk559 and sk574 cell lines. JAK1 was also phosphorylated in one of two cell lines while JAK3 was present but not phosphorylated in any of the cell lines studied. A signal transduction and activator of transcription (STAT)6 was also activated in response to both IL. An insulin receptor substrate (IRS)-1 was constitutively phosphorylated and its phosphorylation level was augmented in response to both IL. These results suggest that the mechanism of signal transduction through IL-13 and IL-4 receptors in human fibroblast cell lines is similar, and this may, at least in part, be responsible for the redundant effects of these two cytokines. In addition, JAK2 tyrosine kinase instead of JAK3 appears to play a major role in IL-4- and IL-13-induced signal transduction in human fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9723696     DOI: 10.1093/intimm/10.8.1103

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  31 in total

Review 1.  Fibrotic disease and the T(H)1/T(H)2 paradigm.

Authors:  Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

2.  Does genetic regulation of IgE begin in utero? Evidence from T(H)1/T(H)2 gene polymorphisms and cord blood total IgE.

Authors:  Xiumei Hong; Hui-Ju Tsai; Xin Liu; Lester Arguelles; Rajesh Kumar; Guoying Wang; Nataliya Kuptsova-Clarkson; Colleen Pearson; Kathryn Ortiz; Anthony Bonzagni; Stephanie Apollon; Lingling Fu; Jacqueline A Pongracic; Robert Schleimer; Patrick G Holt; Howard Bauchner; Xiaobin Wang
Journal:  J Allergy Clin Immunol       Date:  2010-11       Impact factor: 10.793

3.  IL-13 alters mucociliary differentiation and ciliary beating of human respiratory epithelial cells.

Authors:  J Laoukili; E Perret; T Willems; A Minty; E Parthoens; O Houcine; A Coste; M Jorissen; F Marano; D Caput; F Tournier
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

4.  An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response.

Authors:  M G Chiaramonte; D D Donaldson; A W Cheever; T A Wynn
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

Review 5.  Proinflammatory Pathways in the Pathogenesis of Asthma.

Authors:  R Stokes Peebles; Mark A Aronica
Journal:  Clin Chest Med       Date:  2019-03       Impact factor: 2.878

6.  Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4Ralpha, IL-13Ralpha1, and gammac regulates relative cytokine sensitivity.

Authors:  Ilkka S Junttila; Kiyoshi Mizukami; Harold Dickensheets; Martin Meier-Schellersheim; Hidehiro Yamane; Raymond P Donnelly; William E Paul
Journal:  J Exp Med       Date:  2008-10-13       Impact factor: 14.307

7.  Overexpression of interleukin-13 receptor-alpha2 in neuroendocrine malignant pheochromocytoma: a novel target for receptor directed anti-cancer therapy.

Authors:  Edwin W Lai; Bharat H Joshi; Lucia Martiniova; Ritika Dogra; Toshio Fujisawa; Pamela Leland; Ronald R de Krijger; Irina A Lubensky; Abdel G Elkahloun; John C Morris; Raj K Puri; Karel Pacak
Journal:  J Clin Endocrinol Metab       Date:  2009-06-02       Impact factor: 5.958

Review 8.  The immune pathogenesis of scleroderma: context is everything.

Authors:  Matthew B Greenblatt; Antonios O Aliprantis
Journal:  Curr Rheumatol Rep       Date:  2013-01       Impact factor: 4.592

Review 9.  Interleukin-13: prospects for new treatments.

Authors:  C E Brightling; S Saha; F Hollins
Journal:  Clin Exp Allergy       Date:  2009-10-30       Impact factor: 5.018

10.  Therapeutic efficacy of Cintredekin Besudotox (IL13-PE38QQR) in murine lung fibrosis is unaffected by immunity to Pseudomonas aeruginosa exotoxin A.

Authors:  Rogério S Rosada; Ana P Moreira; Fabiani G Frantz; Raj K Puri; Aquilur Rahman; Theodore J Standiford; Carlos R Zárate-Bladés; Célio L Silva; Cory M Hogaboam
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.